Shares of Agile Therapeutics, Inc. (AGRX) are surging over 70% on Tuesday morning despite no stock-related new release from the company.
AGRX is currently trading at $2.1608, up $0.8908 or 70.1417%, on the Nasdaq. The stock opened its trading at $1.67 after closing Monday's trading at $1.27.
Agile Therapeutics, a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch.
For comments and feedback: editorial@rttnews.com